Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: G. Karponi, N. Psatha, C. W. Lederer, J. E. Adair, F. Zervou, N. Zogas, M. Kleanthous, C. Tsatalas, A. Anagnostopoulos, M. Sadelain, I. Riviere, G. Stamatoyannopoulos, E. Yannaki

Journal title: Blood

Journal number: 00064971

Journal publisher: American Society of Hematology

Published year: 2015

Published pages: 616-619

DOI identifier: 10.1182/blood-2015-03-629618

ISSN: 0006-4971